---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-26-000065"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:31:47.387900+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lexicon doubles authorized shares to 900M, adopts expanded 2026 equity plans

## Summary
- Authorized common stock increased from 450M to 900M via Seventh Amended and Restated Certificate of Incorporation.
- Stockholders approved 2026 Equity Incentive Plan, raising share reserve from 75M to 90M shares.
- 2026 Non-Employee Directors' Equity Incentive Plan approved, increasing pool from 4M to 6M shares.
- All 408,434.7 shares of Series B Convertible Preferred converted into 20,421,735 common shares.
- All director nominees elected and other proposals passed with strong majority votes (e.g., auditor ratification 99.3% for).

## SEC filing metadata
- accession: 0001062822-26-000065
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.02, 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/0001062822-26-000065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/lxrx-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-26-000065
- JSON: https://secwatch.observer/filing/0001062822-26-000065.json
- Plain text: https://secwatch.observer/filing/0001062822-26-000065.txt

## Source-grounded claims
- claim_id: 1c8cfc144afa3456a06238051660ab8c0bd73cd0
  claim: LEXICON PHARMACEUTICALS, INC.: Increased authorized common stock from 450,000,000 to 900,000,000 (effective 2026-04-30).
  evidence_excerpt: The Seventh Amended and Restated Certificate of Incorporation increases the number of shares of our authorized Common Stock from 450,000,000 to 900,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282226000065/0001062822-26-000065-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.